exercise induced left arm
play

EXERCISE INDUCED LEFT ARM 2% in the general population. SWELLING - PowerPoint PPT Presentation

4/18/2015 INTRODUCTION The incidence of thoracic outlet syndrome (TOS) is approximately 0.3- EXERCISE INDUCED LEFT ARM 2% in the general population. SWELLING The most common age range is 25 to 40 years. Bala Ramanan, MBBS Venous TOS


  1. 4/18/2015 INTRODUCTION • The incidence of thoracic outlet syndrome (TOS) is approximately 0.3- EXERCISE INDUCED LEFT ARM 2% in the general population. SWELLING • The most common age range is 25 to 40 years. Bala Ramanan, MBBS • Venous TOS accounts for 2-3% of cases. 1 st year vascular surgery fellow • Controversies in the management involve what treatment should be done immediately and which type of treatment should be implemented. Case Presentation Imaging • 37 year old male. • Presented to ED with swelling , purplish discoloration and prominence of the veins in his left upper extremity for 5 days after vigorous exercise. • No previous symptoms , trauma or instrumentation. • PMH: hashimoto’s thyroiditis, psoriasis. • PSH: bilateral inguinal hernia repairs. • Medications: synthroid. • SH: no smoking, alcohol or drug use. Physical Examination • Left upper extremity- non tender, compartments soft, visible veins over the arm, normal motor and sensory exam. • Pulses: Bilateral radial pulses 2+ 1

  2. 4/18/2015 What are the initial management options? Case Management A. Discharge home from ED on lovenox bridge to warfarin. • 87% Started on a heparin drip. B. Anticoagulation with heparin drip, • Underwent catheter directed thrombolysis and mechanical hypercoagulable workup and thrombectomy. discharge home on warfarin for 3-6 months. • Repeat Venogram on POD #1 showed patent subclavian vein with 10% stenosis. He underwent venoplasty of the subclavian vein using 6 C. Heparin drip, venogram and 3% 0% mm and 8 mm balloons with no significant change in the stenosis. catheter directed thrombolysis and . . . . . . . D e . . . c . E h m mechanical thrombectomy. e m h a b t r m o i g w r o o f n e n r e h m o t v i l o t , a a p h l i c D. Open surgical thrombectomy. u r i e g g d r g a r n u a o s r i h c n i a c t p e s n i e p D A O H PRETREATMENT VENOGRAM POST-THROMBOLYSIS VENOGRAM 2

  3. 4/18/2015 POST-VENOPLASTY VENOGRAM How would you further manage this patient? A. Discharge home on low molecular 57% weight heparin bridge to warfarin for 3-6 months. 39% B. Thoracic outlet decompression surgery in the same hospital stay. C. Discharge home on anticoagulation 4% followed by thoracic outlet decompression surgery at a later . . . . e . . . . . r c w p t i o m n l a o n c n o time. e o d e e m t m e o l t o h u h e o e g c r g a i r c a h a r h c o s c i h s D i T D What intervention would you perform to Case Management restore vein patency? 1. Ultrasound-guided retrograde left basilic vein access. 2. Left subclavian nonselective venogram. 70% 3. Left 1st rib resection. A. Intraoperative balloon venoplasty. B. Delayed balloon venoplasty +/- 4. Subclavian venolysis. stent. 5. Percutaneous balloon angioplasty of subclavian vein to 12 mm. C. Intraoperative venolysis/ vein 17% 13% patch. Postoperative course Discharged home on warfarin on POD 5 for 3 months then switched to aspirin. . . t . . s . . a / . v l s p i n s o y o n l o e o l v n a l e b n v o e o e v l v i l i t a t a a b r r e d e p e p o y o a a a r e l r t t n D n I I 3

  4. 4/18/2015 POST BALLOON VENOPLASTY IN OR STEP 1: IMMEDIATE THROMBOLYSIS • Immediate thrombolysis of venous TOS is favored as the syndrome can evolve very rapidly into a chronic stage with irreversible fibrotic changes of the vein. • This can lead to total obliteration with chronic edema and disability. Timing of TOS decompressive surgery STEP 2: PREVENTION OF RECURRENCE • Kunkel and Machleder* in 1989 described and algorithm of initial thrombolysis therapy followed by 3 months of anticoagulation to allow the inflammation to Role of venous stents alone without TOS decompressive surgery subside and then delayed transaxillary first rib resection and scalenectomy in 17 • Urschel et al.*studied 22 patients who had venous stents inserted without TOS patients. decompressive surgery. All 22 stents occluded within 6 weeks after insertion. The • Angie and colleagues# reviewed 18 consecutive patients and for the first time authors concluded that venous stents alone are contraindicated in venous TOS. compared outcomes of 9 patients undergoing immediate surgery and 9 patients undergoing staged therapy with excellent results in the early surgery group. • Meier and colleagues# studied outcome of venous stents after initial thrombolysis • Early decompressive surgery has now been widely adapted for treatment of venous for venous TOS. They observed stent fractures in patients who had venous stents TOS. alone. • In patients unable to receive early decompression- anticoagulation is followed by decompression at a convenient time. *J.M. Kunkel, H.I. Machleder. Arch Surg, 124 (1989), pp. *Urschel HC, Patel AN. Ann Thorac Surg 2003;75:1693-6. 13. 1153–1158 #Meier GH, et al.J Vasc Surg 1996;24:974-83. #Angie et al. Ann Vasc Surg, 15 (2001), pp. 37–42. 4

  5. 4/18/2015 Conclusions Direct interventions on the vein to re-establish normal caliber • Venous TOS occurs in young patients after vigorous • Schneider et al. *described balloon angioplasty alone during the exercise. surgery for TOS decompression in 25 patients. • Immediate thrombolysis is the first line of therapy. • Balloon angioplasty with stent implant as a delayed second • Venous stents alone are contraindicated. intervention has been reported by Hall et al.# and Kreienberg et al.! • Timing of TOS decompression surgery is • Direct surgical intervention- simple venotomy or patch enlargement controversial. of the vein during surgery for TOS decompression has been described • Vein stenosis can be treated with percutaneous by Molina and colleagues$ with 100% success rate in a cohort of 97 patients. angioplasty, venolysis or patch venoplasty. *Schneider DB, et al. J Vasc Surg 2004;40:599-603. #Hall LD,et al. J Vasc Interven Radiol 1995;6:565-70. 16. !Kreienberg PB, et al. J Vasc Surg 2001;33:S100-5. $ Molina et al. J Vasc Surg 2007; 45(2):328-34. 5

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend